SEATTLE, Oct. 14, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the acceptance of a preclinical… Read More
October 14, 2020, VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced Time Is Nephrons, the first-ever lupus nephritis (LN) disease-state awareness campaign… Read More
VANCOUVER, BC, Oct. 9, 2020 /PRNewswire/ — Bold Therapeutics, a clinical-stage biopharmaceutical company, announced that the first patient for the company’s Phase 1b oncology clinical trial has been enrolled at the Cross Cancer Institute… Read More
Combined CompanyWillHave Over $275 Million in Operating Capital andTrade on Nasdaq under the Ticker Symbol “KDNY” VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biotechnology company focused on the discovery, development… Read More
VICTORIA BC, September 25, 2020 (BUSINESSWIRE) – StarFish Medical, Canada’s largest medical device design, development, and manufacturing service provider, announced today that the Winnipeg Ventilator 2.0 has received a Health Canada… Read More
